Kidney360
Sodium-Glucose Cotransporter 2 Inhibitors Prevent Nephrolithiasis in Patients with Diabetes: A TriNetX-Based Real-World Global Comparison.
Chia-Min Liu, Daniel Hsiang-Te Tsai, Hsiu-Ting Tung, Ze-Hong Lu, Edward Chia-Cheng Lai, Chan-Jung Liu
Published: 202510.34067/KID.0000000981
Abstract
BACKGROUND: Nephrolithiasis is a prevalent condition associated with diabetes mellitus (DM) and obesity, yet effective pharmacological preventive options remain limited. Sodium-glucose cotransporter 2 inhibitors (SGLT2i), primarily used to manage typ…
Preview only. Read the full abstract at the source